SERAFAST absorbable violet (3/0) HR-17 needle of 70 CM box of 24 sutures - Serag & Wiessner (JO203276) - Delynov

What is SERAFAST absorbable violet (3/0)?

SERAFAST from the brand Serag-Wiessner is a monofilament, synthetic, and absorbable surgical suture material. This Class III medical device is designed from a segmented copolymer combining glycolide and e-caprolactone. Presented here in 3/0 calibre with a 70cm thread, it is dyed violet (D+C No 2 dye) for optimal visibility during the operative act. Its monofilament structure limits capillarity and traumatic passage through tissues, meeting the requirements of the European Pharmacopoeia for sterile synthetic absorbable monofilament sutures.

What are the clinical indications for this suture?

This rapid absorbable suture is specifically indicated for soft tissue adaptation and performing ligatures. In oral and implant surgery, it is recommended when tissue maintenance is only necessary for a short period, generally up to two weeks. The manufacturer Serag-Wiessner GmbH & Co. KG specifies that its use is ideal for clinical situations not requiring prolonged mechanical stability of the suture material, thus allowing rapid healing of the mucous membranes without the need for a subsequent intervention for thread removal.

What are the technical characteristics of the HR-17 needle?

The reference JO203276 is equipped with an HR-17 type needle. According to the technical nomenclature, the code HR designates a 1/2 circle round-bodied needle, particularly suitable for deep sutures and ligatures. The number 17 indicates a needle body length of 17 mm. Manufactured from high-quality surgical steel, this needle allows precise penetration while minimizing tissue trauma. It is securely swaged to a 70cm thread, offering sufficient length to perform several stitches or complex ligatures safely.

What are the contraindications for the use of SERAFAST?

The SERAFAST device presents specific contraindications related to its resorption kinetics. It must never be used when lasting or prolonged stability of the suture is imperative, such as for the fixation of synthetic implants or heart valves. Its use is strictly prohibited in the central cardiovascular system and the central nervous system. Furthermore, it must not be used in patients with a known allergy to glycolide, e-caprolactone, or the violet dye. Particular caution is recommended for patients with delayed healing.

How does resorption occur and what are the precautions?

SERAFAST is a suture absorbable by hydrolysis. Its loss of tensile strength is rapid, making it appropriate for support needs not exceeding two weeks. The choice of this material must imperatively take into account the rapid resorption characteristics specific to the glycolide and e-caprolactone copolymer. Like any foreign body, it must be used with caution in patients at risk. The practitioner must adapt their suturing technique according to clinical requirements, knowing that this material complies with the strict standards of the European Pharmacopoeia for synthetic monofilaments.

Who is the manufacturer and what standards are respected?

The product is manufactured by Serag-Wiessner GmbH & Co. KG, a recognized manufacturer based in Naila, Germany. This medical device carries the CE1014 marking and is classified as Class III, guaranteeing a high level of safety and compliance according to current European regulations. The suture material rigorously complies with the European Pharmacopoeia (EP) monograph concerning sterile synthetic absorbable monofilament sutures. Each box contains 24 ready-to-use sutures, guaranteeing the traceability and sterility necessary for invasive surgical acts.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.